Citation profile for Andres Roman-Urrestarazu

Andres Roman-Urrestarazu : Citation Profile

University of Cambridge

H index

i10 index

Citations

RESEARCH PRODUCTION:

Articles

Papers

RESEARCH ACTIVITY:

   2 years (2018 - 2020). See details.
   Cites by year: 1
   Journals where Andres Roman-Urrestarazu has often published
   Relations with other researchers
   Recent citing documents: 0.    Total self citations: 2 (40 %)

MORE DETAILS IN:

EconPapers Author's homepage

ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/pro1316
   Updated: 2024-04-18    RAS profile: 2023-01-02
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers

Works with:

Authors registered in RePEc who have co-authored more than one work in the last five years with Andres Roman-Urrestarazu.

Is cited by:

Cites to:

Verick, Sher (2)

Tapia Granados, José (2)

Wasem, Juergen (1)

Jann, Ben (1)

Crivelli, Luca (1)

Willington, Manuel (1)

Sapelli, Claudio (1)

Agostini, Claudio (1)

Islam, Iyanatul (1)

Saavedra, Eduardo (1)

Fischer, Ronald (1)

Main data

Where Andres Roman-Urrestarazu has published?

Journals with more than one article published	# docs
PLOS ONE	6

Recent works citing Andres Roman-Urrestarazu (2024 and 2023)

Year	Title of citing document

Works by Andres Roman-Urrestarazu:

Year	Title	Type	Cited
2019	Brexit threatens the UK’s ability to tackle illicit drugs and organised crime: What needs to happen now? In: Health Policy. [Full Text][Citation analysis]	article	1
2018	Private health insurance in Germany and Chile: two stories of co-existence, segmentation and conflict In: LSE Research Online Documents on Economics. [Full Text][Citation analysis]	paper	1
	In: . [Full Text][Citation analysis]	article	0
2018	Binge alcohol and substance use across birth cohorts and the global financial crisis in the United States In: PLOS ONE. [Full Text][Citation analysis]	article	1
2019	Health-related quality of life in paediatric patients with Type 1 diabetes mellitus using insulin infusion systems. A systematic review and meta-analysis In: PLOS ONE. [Full Text][Citation analysis]	article	0
2019	Mapping novel psychoactive substances policy in the EU: The case of Portugal, the Netherlands, Czech Republic, Poland, the United Kingdom and Sweden In: PLOS ONE. [Full Text][Citation analysis]	article	0
2019	Opioid prescription patterns in Germany and the global opioid epidemic: Systematic review of available evidence In: PLOS ONE. [Full Text][Citation analysis]	article	0
2019	Differences in receipt of opioid agonist treatment and time to enter treatment for opioid use disorder among specialty addiction programs in the United States, 2014-17 In: PLOS ONE. [Full Text][Citation analysis]	article	0
2020	Lifetime prevalence of novel psychoactive substances use among adults in the USA: Sociodemographic, mental health and illicit drug use correlates. Evidence from a population-based survey 2007–2014 In: PLOS ONE. [Full Text][Citation analysis]	article	0